ID

38414

Beschreibung

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma; ODM derived from: https://clinicaltrials.gov/show/NCT01610544

Link

https://clinicaltrials.gov/show/NCT01610544

Stichworte

Versionen (1)
  1. 16.10.19 16.10.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

16. Oktober 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

Englisch

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

1 Formulare  
Criteria
Beschreibung

Criteria

subjects with pathology proven lung cancer or thymic malignancy already enrolled in an nci treatment protocol usingazd6244 in nsclc and imc-a12, in thymoma.
Beschreibung

Carcinoma of lung | Malignant Neoplasm Thymic | Study Subject Participation Status | Treatment Protocols Specified | Non-Small Cell Lung Carcinoma | Thymoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0684249
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0040113
UMLS CUI [3]
C2348568
UMLS CUI [4,1]
C0040808
UMLS CUI [4,2]
C0205369
UMLS CUI [5]
C0007131
UMLS CUI [6]
C0040100
participant must be 18 years or older
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance score of 0 to 2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of this study before any protocol related studies are performed.
Beschreibung

Informed Consent | Comprehension Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C2348563
participants must not be pregnant or intend to become pregnant within 1 week of the last injection of (18)f flt
Beschreibung

Pregnancy Absent | Planned Pregnancy Absent | (18F) fluorothymidine Injection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0032992
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1432709
UMLS CUI [3,2]
C1533685
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
known allergy to fluorothymidine
Beschreibung

Hypersensitivity (18F) fluorothymidine

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1432709
participants for whom enrollment would significantly delay (> 2 weeks) the scheduled standard of care therapy
Beschreibung

Enrollment Causing Delay Standard of Care

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516879
UMLS CUI [1,2]
C0678227
UMLS CUI [1,3]
C0205421
UMLS CUI [1,4]
C2936643
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded
Beschreibung

Comorbidity Interferes with Procedure Investigational | Mental condition Interferes with Procedure Investigational | Comorbidity Interferes with Research results | Mental condition Interferes with Research results

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0184661
UMLS CUI [1,4]
C1517586
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0184661
UMLS CUI [2,4]
C1517586
UMLS CUI [3,1]
C0009488
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C0683954
UMLS CUI [4,1]
C3840291
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0683954
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing > 136 kg (weight limit for scanner table)
Beschreibung

Claustrophobia Severe | Anti-Anxiety Agents Unsuccessful | Body Weight Inappropriate Scanner Device

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008909
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0040616
UMLS CUI [2,2]
C1272705
UMLS CUI [3,1]
C0005910
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C1710020
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures
Beschreibung

Other medical condition Ineligibility Protocol procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1512714
UMLS CUI [1,3]
C2348563
UMLS CUI [1,4]
C0184661
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Carcinoma, Non-Small-Cell Lung NCT01610544

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Carcinoma of lung | Malignant Neoplasm Thymic | Study Subject Participation Status | Treatment Protocols Specified | Non-Small Cell Lung Carcinoma | Thymoma
Item
subjects with pathology proven lung cancer or thymic malignancy already enrolled in an nci treatment protocol usingazd6244 in nsclc and imc-a12, in thymoma.
boolean
C0684249 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0040113 (UMLS CUI [2,2])
C2348568 (UMLS CUI [3])
C0040808 (UMLS CUI [4,1])
C0205369 (UMLS CUI [4,2])
C0007131 (UMLS CUI [5])
C0040100 (UMLS CUI [6])
Age
Item
participant must be 18 years or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance score of 0 to 2
boolean
C1520224 (UMLS CUI [1])
Informed Consent | Comprehension Study Protocol
Item
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of this study before any protocol related studies are performed.
boolean
C0021430 (UMLS CUI [1])
C0162340 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Pregnancy Absent | Planned Pregnancy Absent | (18F) fluorothymidine Injection
Item
participants must not be pregnant or intend to become pregnant within 1 week of the last injection of (18)f flt
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0032992 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1432709 (UMLS CUI [3,1])
C1533685 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hypersensitivity (18F) fluorothymidine
Item
known allergy to fluorothymidine
boolean
C0020517 (UMLS CUI [1,1])
C1432709 (UMLS CUI [1,2])
Enrollment Causing Delay Standard of Care
Item
participants for whom enrollment would significantly delay (> 2 weeks) the scheduled standard of care therapy
boolean
C1516879 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C0205421 (UMLS CUI [1,3])
C2936643 (UMLS CUI [1,4])
Comorbidity Interferes with Procedure Investigational | Mental condition Interferes with Procedure Investigational | Comorbidity Interferes with Research results | Mental condition Interferes with Research results
Item
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C1517586 (UMLS CUI [1,4])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C1517586 (UMLS CUI [2,4])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Claustrophobia Severe | Anti-Anxiety Agents Unsuccessful | Body Weight Inappropriate Scanner Device
Item
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing > 136 kg (weight limit for scanner table)
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0040616 (UMLS CUI [2,1])
C1272705 (UMLS CUI [2,2])
C0005910 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C1710020 (UMLS CUI [3,3])
Other medical condition Ineligibility Protocol procedure
Item
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures
boolean
C3843040 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0184661 (UMLS CUI [1,4])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video